{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Banderol", "Borrelia", "Otoba parvifolia", "Samento", "Uncaria tomentosa", "cat\u2019s claw", "herb\u2013drug interaction"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30602711", "DateCompleted": {"Year": "2019", "Month": "03", "Day": "22"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "12", "Day": "31"}], "Language": ["eng"], "ELocationID": ["137", "10.3390/molecules24010137"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Dec", "Day": "31"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Herb\u207bDrug Interaction Potential of Anti-Borreliae Effective Extracts from <i>Uncaria tomentosa</i> (Samento) and <i>Otoba parvifolia</i> (Banderol) Assessed In Vitro.", "Abstract": {"AbstractText": ["Samento (extract from <i>Uncaria tomentosa</i>) and Banderol (extract from <i>Otoba parvifolia</i>) have been demonstrated to have anti-inflammatory and antimicrobial properties, e.g., against different morphological forms of <i>Borrelia burgdorferi</i>. However, there is hardly any data on the pharmacological safety of these two herbal medicines. This in vitro study aimed at scrutinizing their possible characteristics as perpetrators in pharmacokinetic herbal\u207bdrug interactions. Inhibition of cytochrome P450 enzymes (CYPs) was quantified by commercial kits and inhibition of drug transporters by use of fluorescent probe substrates. Induction was quantified by real-time RT-PCR and activation of pregnane x receptor (PXR) and aryl hydrocarbon receptor (AhR) by reporter gene assays. Organic anion transporting polypeptide 1B1 (OATP1B1) (IC<sub>50</sub> = 0.49 \u00b1 0.28%) and OATP1B3 (IC<sub>50</sub> = 0.65 \u00b1 0.29%) were potently inhibited by Banderol, but only weakly by Samento. CYP3A4 was inhibited about 40% at a Samento concentration of 1%. Samento significantly induced mRNA expression of <i>CYP2J2</i>, <i>UGT1A3</i>, <i>UGT1A9</i>, <i>ABCB1</i>, and <i>SLCO1B1</i> and strongly activated PXR, but hardly AhR. In conclusion, the perpetrator profiles of Samento and Banderol for herb\u207bdrug interactions completely differ. Clinical studies are strongly recommended to clarify whether the effects observed in vitro are of clinical relevance."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. johanna.weiss@med.uni-heidelberg.de."}], "LastName": "Weiss", "ForeName": "Johanna", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "AHR protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Basic Helix-Loop-Helix Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "NR1I2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Pregnane X Receptor"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Aryl Hydrocarbon"}, {"RegistryNumber": "9035-51-2", "NameOfSubstance": "Cytochrome P-450 Enzyme System"}], "MeshHeadingList": [{"QualifierName": ["genetics"], "DescriptorName": "Basic Helix-Loop-Helix Transcription Factors"}, {"QualifierName": [], "DescriptorName": "Borrelia"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cat's Claw"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Cytochrome P-450 Enzyme System"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Myristicaceae"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["genetics"], "DescriptorName": "Pregnane X Receptor"}, {"QualifierName": ["genetics"], "DescriptorName": "Receptors, Aryl Hydrocarbon"}], "CoiStatement": "The author declares no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hon\u00f3rio I.C.G., Bertoni B.W., Telles M.P.C., Braga R.D.S., Fran\u00e7a S.C., Coppede J.D.S., Correa V.S.C., Diniz Filho J.A.F., Pereira A.M.S. Genetic and chemical diversity of Uncaria tomentosa (Willd. ex. Schult.) DC. in the Brazilian Amazon. PLoS ONE. 2017;12:e0177103. doi: 10.1371/journal.pone.0177103.", "ArticleIdList": ["10.1371/journal.pone.0177103", "PMC5419575", "28475604"]}, {"Citation": "Navarro-Hoyos M., Lebr\u00f3n-Aguilar R., Quintanilla-L\u00f3pez J.E., Cueva C., Hevia D., Quesada S., Azofeifa G., Moreno-Arribas M.V., Monagas M., Bartolom\u00e9 B. Proanthocyanidin Characterization and Bioactivity of Extracts from Different Parts of Uncaria tomentosa L. (Cat\u2019s Claw) Antioxidants (Basel) 2017;6:12. doi: 10.3390/antiox6010012.", "ArticleIdList": ["10.3390/antiox6010012", "PMC5384175", "28165396"]}, {"Citation": "Heitzman M.E., Neto C.C., Winiarz E., Vaisberg A.J., Hammond G.B. Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae) Phytochemistry. 2005;66:5\u201329. doi: 10.1002/chin.200517286.", "ArticleIdList": ["10.1002/chin.200517286", "15649507"]}, {"Citation": "Zhang Q., Zhao J.J., Xu J., Feng F., Qu W. Medicinal uses, phytochemistry and pharmaology of the genus Uncaria. J. Ethnopharmacol. 2015;173:48\u201380. doi: 10.1016/j.jep.2015.06.011.", "ArticleIdList": ["10.1016/j.jep.2015.06.011", "26091967"]}, {"Citation": "Reinhard K.-H. Uncaria tomentosa (Willd.) D.C.: Cat\u2018s Claw, U\u00f1a de Gato, or Sav\u00e9ntaro. J. Altern. Complement. Med. 1999;5:143\u2013151. doi: 10.1089/acm.1999.5.143.", "ArticleIdList": ["10.1089/acm.1999.5.143", "10328636"]}, {"Citation": "Schultes R.E., Raffauf R. The Healing Forest: Medicinal and Toxic Plants of Northwest Amazonia. Dioscorides Press; Portland, OR, USA: 1990."}, {"Citation": "Weniger B., Robledo S., Arango G.J., Deharo E., Arag\u00f3n R., Mu\u00f1oz V., Callapa J., Lobstein A., Anton R. Antiprotozoal activities of Colombian plants. J. Ethnopharmacol. 2001;79:103\u2013200. doi: 10.1016/S0378-8741(01)00346-4.", "ArticleIdList": ["10.1016/S0378-8741(01)00346-4", "11694364"]}, {"Citation": "Datar A., Kaur N., Patel S., Luecke D., Sapi E. In vitro effectiveness of samento and banderol herbal extracts on the different morphological forms of Borrelia burgdorferi. Townsend Lett. 2010;7:1\u20134."}, {"Citation": "Stanek G., Wormser G.P., Gray J., Strle F. Lyme borreliosis. Lancet. 2011;379:461\u2013473. doi: 10.1016/S0140-6736(11)60103-7.", "ArticleIdList": ["10.1016/S0140-6736(11)60103-7", "21903253"]}, {"Citation": "Sapi E., Kaur N., Anyanwu S., Luecke D.F., Datar A., Patel S., Rossi M., Stricker R.B. Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect. Drug Resist. 2011;4:97\u2013113.", "ArticleIdList": ["PMC3132871", "21753890"]}, {"Citation": "Meril\u00e4inen L., Herranen A., Schwarzbach A., Gilbert L. Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms. Microbiology. 2015;161:516\u2013527. doi: 10.1099/mic.0.000027.", "ArticleIdList": ["10.1099/mic.0.000027", "PMC4339653", "25564498"]}, {"Citation": "Liu C.X., Yi X.L., Si D.Y., Xiao X.F., He X., Li Y.Z. Herb-drug interactions involving drug metabolizing enzymes and transporters. Curr. Drug Metab. 2011;12:835\u2013849. doi: 10.2174/138920011797470083.", "ArticleIdList": ["10.2174/138920011797470083", "21619518"]}, {"Citation": "Budzinski J.W., Foster B.C., Vandenhoek S., Arnason J.T. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine. 2000;7:273\u2013282. doi: 10.1016/S0944-7113(00)80044-6.", "ArticleIdList": ["10.1016/S0944-7113(00)80044-6", "10969720"]}, {"Citation": "L\u00f3pez Galera R.M., Ribera Pascuet E., Esteban Mur J.I., Montoro Ronsano J.B., Ju\u00e1rez Gimin\u00e9z J.C. Interaction between cat\u2019s claw and protease inhibitors atazanavir, ritonavir and saquinavir. Eur. J. Clin. Pharmacol. 2008;64:1235\u20131236. doi: 10.1007/s00228-008-0551-1.", "ArticleIdList": ["10.1007/s00228-008-0551-1", "18712519"]}, {"Citation": "Rodrigues A.D., Roberts E.M., Mulford D.J., Yao Y., Ouellet D. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily. Drug Metab. Dispos. 1997;25:623\u2013630.", "ArticleIdList": ["9152603"]}, {"Citation": "Fuhr U. Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans. Clin. Pharmacokinet. 2000;38:493\u2013504. doi: 10.2165/00003088-200038060-00003.", "ArticleIdList": ["10.2165/00003088-200038060-00003", "10885586"]}, {"Citation": "Izzo A.A. Herb-drug interactions: An overview of the clinical evidence. Fundam. Clin. Pharmacol. 2005;19:1\u201316. doi: 10.1111/j.1472-8206.2004.00301.x.", "ArticleIdList": ["10.1111/j.1472-8206.2004.00301.x", "15660956"]}, {"Citation": "Xu M., Ju W., Hao H., Wang G., Li P. Cytochrome P450 2J2: Distribution, function, regulation, genetic polymorphisms and clinical significance. Drug Metab. Rev. 2013;45:311\u2013352. doi: 10.3109/03602532.2013.806537.", "ArticleIdList": ["10.3109/03602532.2013.806537", "23865864"]}, {"Citation": "Kavallaris M., Madafiglio J., Norris M.D., Haber M. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. Biochem. Biophys. Res. Commun. 1993;190:79\u201385. doi: 10.1006/bbrc.1993.1013.", "ArticleIdList": ["10.1006/bbrc.1993.1013", "8093660"]}, {"Citation": "Milane A., Fernandez C., Vautier S., Bensimon G., Meininger V., Farinotti R. Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier. J. Neurochem. 2007;103:164\u2013173. doi: 10.1111/j.1471-4159.2007.04772.x.", "ArticleIdList": ["10.1111/j.1471-4159.2007.04772.x", "17635670"]}, {"Citation": "Muni\u0107 V., Kelneri\u0107 Z., Mikac L., Erakovi\u0107 Haber V. Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays. Eur. J. Pharm. Sci. 2010;41:86\u201395. doi: 10.1016/j.ejps.2010.05.016.", "ArticleIdList": ["10.1016/j.ejps.2010.05.016", "20621639"]}, {"Citation": "Weiss J., Dormann S.M., Martin-Facklam M., Kerpen C.J., Ketabi-Kiyanvash N., Haefeli W.E. Inhibition of P-glycoprotein by newer antidepressants. J. Pharmacol. Exp. Ther. 2003;305:197\u2013204. doi: 10.1124/jpet.102.046532.", "ArticleIdList": ["10.1124/jpet.102.046532", "12649369"]}, {"Citation": "Fr\u00f6hlich M., Albermann N., Sauer A., Walter-Sack I., Haefeli W.E., Weiss J. In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins. Biochem. Pharmacol. 2004;68:2409\u20132416. doi: 10.1016/j.bcp.2004.08.026.", "ArticleIdList": ["10.1016/j.bcp.2004.08.026", "15548387"]}, {"Citation": "Weiss J., Rose J., Storch C.H., Ketabi-Kiyanvash N., Sauer A., Haefeli W.E., Efferth T. Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J. Antimicrob. Chemother. 2007;59:238\u2013245. doi: 10.1093/jac/dkl474.", "ArticleIdList": ["10.1093/jac/dkl474", "17202245"]}, {"Citation": "Weiss J., Theile D., Spalwisz A., Burhenne J., Riedel K.D., Haefeli W.E. Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells. Biochem. Pharmacol. 2013;85:265\u2013273. doi: 10.1016/j.bcp.2012.11.020.", "ArticleIdList": ["10.1016/j.bcp.2012.11.020", "23219525"]}, {"Citation": "Peters T., Lindenmaier H., Haefeli W.E., Weiss J. Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein. Naunyn Schmiedebergs Arch. Pharmacol. 2006;372:291\u2013299. doi: 10.1007/s00210-005-0022-5.", "ArticleIdList": ["10.1007/s00210-005-0022-5", "16365780"]}, {"Citation": "Weiss J., Kocher J., Mueller C., Rosenzweig S., Theile D. Impact of enzalutamide and its main metabolite N-desmethyl enzalutamide on pharmacokinetically important drug metabolizing enzymes and drug transporters. Biopharm. Drug Dispos. 2017;38:517\u2013525. doi: 10.1002/bdd.2103.", "ArticleIdList": ["10.1002/bdd.2103", "28865089"]}, {"Citation": "Albermann N., Schmitz-Winnenthal F.H., Z\u2019graggen K., Volk C., Hoffmann M.M., Haefeli W.E., Weiss J. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem. Pharmacol. 2005;70:949\u2013958. doi: 10.1016/j.bcp.2005.06.018.", "ArticleIdList": ["10.1016/j.bcp.2005.06.018", "16054595"]}, {"Citation": "Gaedigk A., Baker D.W., Totah R.A., Gaedigk R., Pearce R.E., Vyhlidal C.A., Zeldin D.C., Leeder J.S. Variability of CYP2J2 expression in human fetal tissues. J. Pharmacol. Exp. Ther. 2006;319:523\u2013532. doi: 10.1124/jpet.106.109215.", "ArticleIdList": ["10.1124/jpet.106.109215", "PMC1876721", "16868033"]}, {"Citation": "Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2003;3:RESEARCH0034.", "ArticleIdList": ["PMC126239", "12184808"]}, {"Citation": "Zisowsky J., Koegel S., Leyers S., Devarakonda K., Kassack M.U., Osmak M., Jaehde U. Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells. Biochem. Pharmacol. 2007;73:298\u2013307. doi: 10.1016/j.bcp.2006.10.003.", "ArticleIdList": ["10.1016/j.bcp.2006.10.003", "17097621"]}]}], "History": [{"Year": "2018", "Month": "12", "Day": "4"}, {"Year": "2018", "Month": "12", "Day": "23"}, {"Year": "2018", "Month": "12", "Day": "26"}, {"Year": "2019", "Month": "1", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["30602711", "PMC6337116", "10.3390/molecules24010137", "molecules24010137"]}}]}